Overview

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia

Status:
Enrolling by invitation
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This study is being done to research the usefulness of PET/CT imaging for measuring brain inflammation and its relation to Alzheimer's Disease. Additionally, researchers as looking to learn more about the side effects of a new radioactive tracer (radiotracer) C-11 ER176.
Phase:
Phase 2
Details
Lead Sponsor:
Val Lowe